Scientists decode genome of parasite behind malaria relapseOctober 9th, 2008 - 2:46 pm ICT by ANI
London, Oct 9 (ANI): Scientists at a New York University have decoded the complete genetic sequence of the parasite Plasmodium vivax - the leading cause of relapsing malaria - and compared it with the genomes of other species of malaria parasites.
The discovery offers insight into distinctive genetic features of P. vivax, and may lead to new tools to prevent and treat P. vivax malaria.
Although the infection is rarely fatal, it causes severe clinical symptoms that include repeated episodes of high fever followed by headache, chills and profuse sweating, often accompanied by vomiting, diarrhea and enlargement of the spleen.
Patients treated for the primary blood stage infection but not specifically for dormant disease in the liver are at substantial risk of relapse.
Co-authors at the Institute for Genomic Research/J. Craig Venter Institute in Rockville, Md., and their colleagues, said that the P. vivax gene sequence will drive research in three key areas - study of the genetic diversity of P. vivax, the problem of drug resistance and the phenomenon of P. vivax relapse.
“Plasmodium vivax relapse presents serious challenges to scientists and doctors alike. Completion of the P. vivax genome promises to provide new insights into the biology of vivax malaria and new leads for therapies and vaccines,” Nature quoted National Institute of Allergy and Infectious Diseases (NIAID) Director Anthony S. Fauci, M.D, as saying.
One limitation for researchers has been that P. vivax cannot be grown in the laboratory, making it a relatively neglected area of study.
“With the publication of the first genome sequence, we hope to reverse this trend and provide a resource for scientists to pursue studies on this important parasite,” says lead author Jane M. Carlton, Ph.D., of the New York University Langone Medical Center.
Four species of Plasmodium parasite commonly cause malaria in humans: P. falciparum, P. malariae, P. ovale and P. vivax.
According to the researchers, although P. vivax resembles the other three species of human malaria parasites, it has novel gene families that encode for potential alternative pathways into red blood cells not recognized previously.
Importantly, Carlton’’s team identified some P. vivax genes with similarities to genes in other organisms, such as yeast, that are responsible for dormancy.
These genes may allow scientists to study the mechanisms of the dormant liver stage P. vivax and perhaps find ways to disrupt it.
The study appears in the Oct. 9 issue of Nature. (ANI)
- Human malarial parasite came from gorillas, not chimps - Sep 23, 2010
- New study could improve diagnosis and treatment of malaria - Sep 09, 2010
- New class of compounds to combat malaria - Nov 20, 2011
- Re-engineering mosquito's immunity to block malaria - Dec 29, 2011
- How sickle haemoglobin protects against malaria - Apr 29, 2011
- Dispersing fungal spores over water kills malaria mosquito larvae - Feb 21, 2011
- Boffins create malaria-proof mosquito - Jul 16, 2010
- Monkeys main reservoir of human malaria in SE Asia - Apr 08, 2011
- Resistance to malaria drug rings alarm bells - Apr 08, 2012
- Genes that aid antimalarial drug resistance identified - Apr 22, 2011
- Scientists assemble genome from DNA of single bug - Sep 19, 2011
- New way found to kill malaria parasite - Mar 09, 2011
- Novel anti-malarial drug candidate discovered - Sep 03, 2010
- New discovery opens up novel strategy for combating malaria - Mar 09, 2011
- New gene study paves way for more anti-malaria treatments - Oct 11, 2010
Tags: anthony s fauci, craig venter institute, director anthony, drug resistance, gene sequence, genetic diversity, genetic features, genetic sequence, genome sequence, high fever, institute for genomic research, j craig venter, j craig venter institute, malaria parasites, malariae, national institute of allergy and infectious diseases, new insights, new york university, parasite plasmodium, plasmodium vivax